<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-039162</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Association between serum interleukin 10 level and development of heart failure in acute myocardial infarction patients treated by primary angioplasty</dc:title>
<dc:description xml:lang="en">Introduction and objectives. Interleukin 10 (IL-10) is an anti-inflammatory cytokine that inhibits the synthesis of proinflammatory cytokines. It has been shown that IL-10 is released into the circulation during post-ischemic myocardial reperfusion. The objective of this study was to determine whether the serum IL-10 concentration in patients with acute myocardial infarction who were undergoing primary angioplasty was related to the subsequent presence or absence of heart failure. Patients and method. The study included 65 patients who underwent successful primary angioplasty. During their subsequent stay in the coronary unit, their maximum degree of heart failure was recorded. Patients were then divided into 2 groups: group A patients were in Killip class I and group B patients in Killip classes II-IV. The serum IL-10 concentration was measured during the 24 hours following admission to the coronary unit. Results. The 2 groups were similar with regard to age, sex, and coronary risk factors. The IL-10 concentration was significantly higher in the group of patients with acute myocardial infarction without heart failure than in the group with heart failure (30.4±10.8 vs 19.8±7.9 pg/mL; P&lt;.001). Conclusions. In patients with acute myocardial infarction who had undergone successful primary angioplasty, the serum IL-10 concentration measured during the following 24 hours was significantly higher in those who did not develop heart failure. These findings suggest that this anti-inflammatory cytokine has a protective effect on the myocardium during ischemia or reperfusion, or both</dc:description>
<dc:creator>Domínguez Rodríguez, Alberto</dc:creator>
<dc:creator>Abreu González, Pedro</dc:creator>
<dc:creator>García González, Martín J</dc:creator>
<dc:creator>Ferrer Hita, Julio</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción y objetivos. La interleucina 10 (IL-10) es una citocina con propiedades antiinflamatorias capaz de inhibir la síntesis de citocinas proinflamatorias. Se ha demostrado que la IL-10 se libera al torrente sanguíneo durante la reperfusión miocárdica postisquémica. El objetivo de este estudio fue determinar las concentraciones séricas de IL-10 en pacientes con infarto agudo de miocardio (IAM) tratados con angioplastia primaria y relacionarlas con la presencia o ausencia posterior de insuficiencia cardíaca (IC). Pacientes y método. Se incluyó en el estudio a 65 pacientes a los que se realizó angioplastia primaria con éxito. Posteriormente, durante su estancia en la unidad coronaria, se registró el máximo grado de IC. La población de estudio fue dividida en 2 grupos: grupo A (clase Killip I) y B (clases Killip II, III y IV). Las concentraciones séricas de IL- 10 se determinaron durante las primeras 24 h posteriores a su admisión en la unidad coronaria. Resultados. Ambos grupos fueron similares en edad, sexo y factores de riesgo coronario. En el grupo de pacientes con IAM sin IC, las concentraciones de IL-10 fueron mayores que en el grupo de pacientes con IC (30,4 ± 10,8 frente a 19,8 ± 7,9 pg/ml; p &lt; 0,001). Conclusiones. En los pacientes con IAM en los que se realiza con éxito una angioplastia primaria, la concentración sérica de IL-10, determinada en las primeras 24 h del evento, está más elevada cuando no se desarrolla IC. Estos hallazgos sugieren que esta citocina antiinflamatoria ejerce un efecto protector del miocardio durante la isquemia y/o la reperfusión</dc:description>
<dc:source>Rev Esp Cardiol;58(6): 626-630, jun. 2005. tab, graf</dc:source>
<dc:identifier>ibc-039162</dc:identifier>
<dc:title xml:lang="es">Asociación entre concentraciones séricas de interleucina 10 y desarrollo de insuficiencia cardíaca en pacientes con infarto agudo de miocardio tratados con angioplastia primaria</dc:title>
<dc:subject>^d24560</dc:subject>
<dc:subject>^d28623</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d9395^s22067</dc:subject>
<dc:subject>^d3341^s22045</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30178^s22074</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d30030^s22062</dc:subject>
<dc:subject>^d29203^s22045</dc:subject>
<dc:subject>^d24519</dc:subject>
<dc:subject>^d9395^s22062</dc:subject>
<dc:subject>^d6486^s22027</dc:subject>
<dc:subject>^d14384</dc:subject>
<dc:type>article</dc:type>
<dc:date>200506</dc:date>
</metadata>
</record>
</ibecs-document>
